Estimated number and percentage of US adults with atherosclerotic cardiovascular disease recommended add-on lipid-lowering therapy by the 2018 AHA/ACC multi-society cholesterol guideline - Concepedia

Concepedia

Publication | Open Access

Estimated number and percentage of US adults with atherosclerotic cardiovascular disease recommended add-on lipid-lowering therapy by the 2018 AHA/ACC multi-society cholesterol guideline

DOI Full Paper Access

14

Citations

20

References

2022

Year

Chibuike J Alanaeme, Vera Bittner, Todd M. Brown, Lisandro D. Colantonio, Nafeesa Dhalwani, Jenna Jones, Bethany Kalich, Jason Exter, Elizabeth A. Jackson, Emily B. Levitan,

American Heart Journal Plus Cardiology Research and Practice

Abstract

The majority of US adults with ASCVD are recommended add-on lipid-lowering therapy by the 2018 AHA/ACC cholesterol guideline but few are receiving it.

References

	Year	Citations

Page 1